Nikolova E B, Tomana M, Russell M W
Department of Microbiology, University of Alabama at Birmingham 35294.
Scand J Immunol. 1994 Mar;39(3):275-80. doi: 10.1111/j.1365-3083.1994.tb03371.x.
Polyclonal human secretory IgA1 and IgA2 antibodies to a bacterial protein antigen Streptococcus mutans AgI/II, and polyclonal human serum IgA1 and IgA2 antibodies to staphylococcal alpha-toxin, were found to interfere with antigen-mediated C3b fixation. In fluid phase, immune complexes of antigen and IgA failed to fix C3b, whereas antigen-IgG complexes did fix C3b. Partial removal of glycan chains with Streptococcus mitis SK96 glycosidases diminished the capacity of IgA antibodies to interfere with antigen-mediated C3b fixation by the alternative complement pathway. The authors conclude that native serum or secretory IgA antibodies suppress C3b fixation, and that the glycan chains play a significant role in maintaining this property.
研究发现,针对细菌蛋白抗原变形链球菌AgI/II的多克隆人分泌型IgA1和IgA2抗体,以及针对葡萄球菌α毒素的多克隆人血清IgA1和IgA2抗体,可干扰抗原介导的C3b固定。在液相中,抗原与IgA的免疫复合物无法固定C3b,而抗原-IgG复合物则能固定C3b。用缓症链球菌SK96糖苷酶部分去除聚糖链,会降低IgA抗体通过替代补体途径干扰抗原介导的C3b固定的能力。作者得出结论,天然血清或分泌型IgA抗体可抑制C3b固定,且聚糖链在维持该特性中起重要作用。